Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab.

Transl Oncol · 2019 · PMC6423363 · PMID 30877976

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a trend towards significanceP < .10so close (0.05 < p ≤ 0.1)

loss), Ki67, as well as each of the markers that was found to be significant or revealed a trend towards significance in the univariate analyses ( P < .10).

also in 2,760 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.